McKesson has signed a definitive agreement for a $2.5 billion controlling stake in a subsidiary of Florida Cancer Specialists & Research Institute, a physician-owned oncology clinic operator.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
